Lombard Odier Asset Management (USA)’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-43,500	Closed	-$6.8M	–	256
2014 Q3	$6.8M	Sell	43,500 -6,500	-13%	-$942K	0.47%	70
2014 Q2	$6.17M	Buy	+50,000	New	+$5.53M	0.32%	87
2014 Q1	–	Sell	-115,000	Closed	-$10.3M	–	233
2013 Q4	$10.3M	Buy	115,000 +25,000	+28%	+$1.99M	0.44%	75
2013 Q3	$6.02M	Sell	90,000 -10,000	-10%	-$689K	0.3%	71
2013 Q2	$6.62M	Buy	+100,000	New	+$5.72M	0.37%	78

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s SLXP Position: Q4 2014 in Review

Lombard Odier Asset Management (USA) sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2014, closing a stake of 43,500 shares — an estimated $6.8M sold.

Lombard Odier Asset Management (USA) first reported a position in SLXP in Q2 2013 and held it in 5 quarters. The position peaked at $10.3M in Q4 2013. 346 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

Lombard Odier Asset Management (USA) reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2014 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 43,500 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $6.8M.
Lombard Odier Asset Management (USA) first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 5 quarters.
Lombard Odier Asset Management (USA)'s SALIX PHARMACEUTICALS LTD DEL position peaked at $10.3M in Q4 2013.
346 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2014, filed 17 Feb 2015.